Dr. Andrew M. Roecker
Submitted by c-dunbar on Sun, 01/04/2009 - 9:51pm.
Associate Professor of Pharmacy Practice
Pharmacy Practice
RE238
525 S. Main Street
Ada, OH 45810
a-roecker@onu.edu
419-772-2283
Dr. Roecker's area of interest lies in clinical therapeutics, or the treatment of a patient's diseases and/or disorders using both pharmacologic and non-pharmacologic approaches. Dr. Roecker's main interests are in the infectious disease and oncology disciplines, but general therapeutics is imperative to a pharmacist's knowledge base. Evidence-based medicine is crucial to up-to-date clinical therapeutics and allowing for appropriate dissemination of that information allows for an increased presence of pharmacy in the clinical medicine team.
Current Course Curriculum:
PHPR 402 - Patient Care Assessment Module 2
BSPC 442 - Infectious Disease Module - Coordinator
BSPC 544 - Endocrine/Musculoskeletal System Module
BSPC 545 - Oncology/Gastrointestinal System Module
BSPC 546 - Capstone Pharmacy Practice Module
PHBS 545 - Drugs of Abuse - Elective
Professional Experience:
Collaborative practice agreement with Riverside Methodist Hospital in Columbus, Ohio practicing clinical pharmacy in the critical care and general medicine environments during the academic year. This was established in the fall quarter 2007-08.
Contingent pharmacist at Select Specialty Hospitals of Columbus, Ohio. This is a long term/acute care hospital.
Selected Presentations:
• Treating HIV/AIDS in 2008 - Ohio Northern Alumni Event - Cleveland, Ohio - February 7, 2008
• Cultural Competency in Pharmacy and Healthcare - Ohio Pharmacist Association Annual Meeting - Columbus, Ohio - April 11, 2008
• Alzheimer's Disease: The Role of the Pharmacist and Pharmacotherapy - Medco Health in Las Vegas, Nevada - June 22, 2008
• Medication Therapy Management for the Patient with Hypertension - Cardinal Retail Business Conference 2008 - Orlando, Florida - July 23, 2008
• Treatment of Heart Failure - Pharmacotherapy Update - Cardinal Retail Business Conference 2008 - Orlando, Florida - July 24, 2008
Education:
- PharmD, Ohio Northern University, Ada, Ohio 2000
- Board Certification in Pharmacotherapy - December 2005 through present
Selected Publications:
• A Patient Chart - co-authored with Heather P. Roecker, PharmD. Copyrighted April 15, 2004 (TXu1-173-383)
• Pope SD, Roecker AM. Dalbavancin: a novel lipoglycopeptide antibacterial. Pharmacotherapy 2006; 26(7):908-18.
• Roecker AM, Allison JC, Kisor DF. Nelarabine: efficacy in the treatment of clinical malignancies. Future Oncology 2006; 2(4): 441-8.
• Pope SD, Roecker AM. Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections. Exp Opin Pharmacother 2007; 8(9): 1245-61.
• Roecker AM. Pneumonia treatment 2007. Continuing Education Article for Ohio Northern University Raabe College of Pharmacy website - available at http://www.onu.edu/pharmacy/pharmacy_ce. Posted: September 2007.
• Roecker AM, Pope SD. Dalbavancin: a lipoglycopeptide antibacterial for gram-positive infections. Exp Opin Pharmacother 2008; 9(10): 1745-54.
• Pope SD, Roecker AM. Dalbavancin: a novel lipoglycopeptide antibacterial. Pharmacotherapy 2006; 26(7):908-18.
• Roecker AM, Allison JC, Kisor DF. Nelarabine: efficacy in the treatment of clinical malignancies. Future Oncology 2006; 2(4): 441-8.
• Pope SD, Roecker AM. Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections. Exp Opin Pharmacother 2007; 8(9): 1245-61.
• Roecker AM. Pneumonia treatment 2007. Continuing Education Article for Ohio Northern University Raabe College of Pharmacy website - available at http://www.onu.edu/pharmacy/pharmacy_ce. Posted: September 2007.
• Roecker AM, Pope SD. Dalbavancin: a lipoglycopeptide antibacterial for gram-positive infections. Exp Opin Pharmacother 2008; 9(10): 1745-54.